It has been about a month since the last earnings report for AllScripts Healthcare (MDRX). Shares have lost about 7% in that time frame, underperforming the S&P 500. Will the recent negative trend ...

CHICAGO--(BUSINESS WIRE)--Allscripts (NASDAQ: MDRX) has been ranked number one of 68 named EHR vendors in a Black Book Research user satisfaction survey globally. The report surveyed 4,056 current EHR ...

Allscripts has agreed to pay $145 million to resolve potential civil and criminal liability in connection to a Department of Justice investigation into the business practices of Practice Fusion, a ...

In its third-quarter 2022 earnings report posted Nov. 3, revenues for Veradigm, Allscripts’ life sciences and payer business, were $145 million compared with $137 million in the previous third quarter ...

CHICAGO--(BUSINESS WIRE)--Allscripts (NASDAQ: MDRX) has been recognized as the top-rated electronic health record vendor for community hospitals according to new survey results from Black Book ...

EHR vendor Allscripts reported a loss of $182.2 million in 2019, a plummeting bottom line compared to 2018's $407.8 million profit. The loss came despite slight topline growth. The Chicago-based ...

The life sciences leg of the Veradigm data analytics business is gaining traction as the industry shifts to real-world evidence as a fundamental pillar of drug discovery, Allscripts executives said.

CHICAGO--(BUSINESS WIRE)-- Allscripts (NASDAQ:MDRX) announced today the execution of a definitive agreement to sell its CarePort Health (“CarePort”) business to WellSky Corp., a global health and ...

Allscripts said clients using its Professional EHR experienced unscheduled downtime Dec. 17, but that the issue has since been resolved, a company spokesperson told Becker's Hospital Review Dec. 19.

On February 21, Allscripts Healthcare Solutions is presenting Q4 earnings. Analysts on Wall Street expect Allscripts Healthcare Solutions will release earnings per share of $0.208. Track Allscripts ...

Allscripts has agreed to sell its CarePort Health business to WellSky, which is backed by TPG Capital and Leonard Green & Partners. The price of the sale is $1.35 billion. William Blair and J.P.

Raleigh Medical Group is a multispecialty group that serves the Research Triangle area of North Carolina with 115,000 patient visits a year in its internal medicine, gastroenterology, dermatology and ...